Potent anti-diabetic effects of MHY908, a newly synthesized PPAR α/γ dual agonist in db/db mice.
Peroxisome proliferator-activated receptor (PPAR) α/γ dual agonists have been developed to alleviate metabolic disorders and have the potential to be used as therapeutic agents for the treatment of type 2 diabetes. In this study, we investigated the effects of a newly synthesized PPAR α/γ dual agoni...
Guardado en:
Autores principales: | Min Hi Park, Ji Young Park, Hye Jin Lee, Dae Hyun Kim, Daeui Park, Hyoung Oh Jeong, Chan Hum Park, Pusoon Chun, Hyung Ryong Moon, Hae Young Chung |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d41df04f737e4e5584b10e4c0ef5c922 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Artemether Regulates Metaflammation to Improve Glycolipid Metabolism in db/db Mice
por: Fu W, et al.
Publicado: (2020) -
Renoprotective Effect of Formononetin by Suppressing Smad3 Expression in Db/Db Mice
por: Lv J, et al.
Publicado: (2020) -
Valsartan alleviates the blood–brain barrier dysfunction in db/db diabetic mice
por: Longxue Cai, et al.
Publicado: (2021) -
Qihu Preparation Ameliorates Diabetes by Activating the AMPK Signaling Pathway in db/db Mice
por: Zeng H, et al.
Publicado: (2021) -
Vascular endothelial growth factor-receptor 1 inhibition aggravates diabetic nephropathy through eNOS signaling pathway in db/db mice.
por: Keun Suk Yang, et al.
Publicado: (2014)